Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib with RT and Temozolomide in Newly-Diagnosed Glioblastoma
NCT00441142Phase 2Completed
- Start
- May 2007
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vandetanib in glioblastoma (GBM), Gliosarcoma (GS). Started May 2007; status: completed.
02
Drugs
vandetanib
03
Conditions
glioblastoma (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT00441142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441142.